Disclosure Of Intangible Assets [Text Block]

Ascelia Pharma - Filing #689421

Concept 2022-01-01 to
2022-12-31
As at
2022-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
Disclosure of intangible assets [text block]
Disclosure of detailed information about intangible assets [text block]
Disclosure of detailed information about intangible assets [abstract]
Disclosure of detailed information about intangible assets [line items]
Reconciliation of changes in intangible assets other than goodwill [abstract]
Intangible assets other than goodwill
57 074 SEK
57 063 SEK
Research and development expense
118 113 SEK
107 574 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.